Abstract
Beryllium is one of the lightest metals, with unique mechanical, physical, and nuclear properties that allow major applications in the aircraft and aerospace industries as well as for nuclear reactors and defense. An estimated 300,000 workers are exposed to beryllium during ore extraction, processing, and manufacturing. Potential toxicities include acute and chronic beryllium disease (CBD) and lung cancer. Skin manifestations include irritant and allergic contact dermatitis, chemical ulcers, and ulcerating and dermal granulomas. Diagnosis of CBD includes (1) a history of beryllium exposure, (2) a positive lymphocyte proliferation test (BeLPT) either from blood or bronchoalveolar lavage, and (3) compatible pathology on lung biopsy. Beryllium sensitization (BeS) occurs with (1) and (2) in the absence of lung pathology. The BeLPT has been the cornerstone of both medical surveillance and the diagnosis of BeS and CBD and, in the occupational and pulmonary settings, has mostly replaced the beryllium patch test because of multiple reports of patch test sensitization. Contact stomatitis to dental alloys has been reported in the more recent dermatology literature, with beryllium patch testing recommended primarily on an aimed rather than a screening basis. Determinants of progression from BeS to CBD are uncertain, but higher beryllium exposures and the presence of a genetic variant in the HLA-DP β-chain appear to increase the risk. The US Occupational Health and Safety Administration has just issued a new permissible exposure limit (PEL) standard dramatically reducing the allowed workroom air concentration of beryllium. In addition, standard industrial hygiene controls including personal protective clothing and equipment are required since the PEL for beryllium does not always protect workers from dermal exposure and skin sensitization.
This is a preview of subscription content, log in via an institution.
References
Stonehouse AJ, Zenczak S. Properties, production processes and applications. In: Rossman MD, Preuss OP, Powers MB, editors. Beryllium biomedical and environmental aspects. Baltimore: Williams and Wilkins. p. 27–58. 319pp.
Strupp C. Beryllium metal I. Experiment results on acute oral toxicity, local skin and eye effects and genotoxicity. Ann Occup Hyg. 2011;55:30–42.
Balmes JR, Abraham JL, Dweik RA, et al. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med. 2014;190:e34–59.
Powers MB. History of beryllium, Chapter 2 in 58. In: Rossman MD, Preuss OP, Powers MB, editors. Beryllium biomedical and environmental aspects. Baltimore: Williams and Wilkins. 319pp.
Van Ordstrand HS, Hughes R, Carmody MG. Chemical pneumonia in workers extracting beryllium oxide. Cleve Clin Q. 1943;10:10.
Curtis GH. Cutaneous hypersensitivity due to beryllium, a study of thirteen cases. Arch Dermatol Syph. 1951;54:470–82.
Denardi JM, Van Ordstrand HS, Curtis GH, Sielinski J. Berylliosis; summary and survey of all clinical types observed in a twelve-year period. AMA Arch Ind Hyg Occup Med. 1953;8:1–24.
Van Ordstrand HS, Netherton EW, De Nardi JM, Carmody MG. Beryllium and skin granulomas from a broken fluorescent light tube. Cleve Clin Q. 1950;17:34–7.
Epstein WL. Commentary and update: beryllium granulomas of the skin: a small window to understanding. Cleve Clin Q. 1983;50:73–5.
Hardy HL, Tabershaw IR. Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds. J Ind Hyg Toxicol. 1946;28:197–211.
Hardy HL, Rabe EW, Lorch S. United States beryllium case registry (1952-1966); review of its methods and utility. J Occup Med. 1967;9:271–6.
Jones-Williams W. Pathology and histopathology of chronic beryllium disease. Chapter 13 pp151–160. In: Rossman MD, Preuss OP, Powers MB, editors. Beryllium biomedical and environmental aspects. Baltimore: Williams and Wilkins. 319pp.
Epstein WL. Cutaneous effects of beryllium. Chapter 9 pp 113–117. In: Rossman MD, Preuss OP, Powers MB, editors. Beryllium biomedical and environmental aspects. Baltimore: Williams and Wilkins. 319pp.
Rossman MD. Chronic beryllium disease, a hypersensitivity disorder. Appl Occup Environ Hyg. 2001;16:615–8.
Cummings KJ, Stefaniak AB, Virji MA, et al. A reconsideration of acute beryllium disease. Environ Health Perspect. 2009;11:1250–6.
Maier LA, Martyny JW, Liang J, et al. Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med. 2008;177:1012–7.
Vilaplana J, Romaguera C, Grimalt F. Occupational and non-occupational allergic contact dermatitis from beryllium. Contact Dermatitis. 1992;26:295–8.
Haberman AL, Pratt M, Storrs FJ. Contact dermatitis from beryllium in dental alloys. Contact Dermatitis. 1993;28:17–162.
Toledo F, Silvestre JF, Cuesta L, Latorre N, Monteagudo A. Contact allergy to beryllium chloride: report of 12 cases. Contact Dermatitis. 2011;64:104–9.
Sneddon IB. Beryllium disease. Postgrad Med J. 1968;34:262–7.
Berlin JM, Taylor JS, Sigel JE, et al. Beryllium dermatitis. J Am Acad Dermatol. 2003;49:939–41.
Kirshen C, Pratt M. Dental allergic contact dermatitis: an interesting case series and review of the literature. Dermatitis. 2012;23:222–6.
Newman LS, Maier LA. Chronic beryllium disease (berylliosis). UpToDate 2016. Accessed 7 June 2016.
Curtis GH. The diagnosis of beryllium disease, with special reference to the patch test. AMA Arch Ind Health. 1959;19:150–3.
Waksman BH. The diagnosis of beryllium disease with special reference to the patch test; discussion of paper by Dr Curtis. AMA Arch Ind Health. 1959;19:154–6.
Sneddon IB. Berylliosis, a case report. Br Med J. 1955;1(4928):1448–50.
Sneddon IB. Berylliosis. Proc R Soc Med. 1955;48:175–7.
Henderson WR, Fukuyama K, Epstein WL, et al. In vitro demonstration of delayed hypersensitivity in patients with berylliosis. J Invest Dermatol. 1972;58:5–7.
Bobka CA, Stewart LA, Engelken GA, et al. Comparison of in vivo and in vitro measures of beryllium sensitization. J Occup Environ Med. 1997;39:540–7.
Costa AL, Salvador JFS, Perez-Crespo M, et al. Late reactions to beryllium: report of two cases. Contact Dermatitis. 2008;59:190–1.
Bircher AJ. Patch tests with beryllium salts. Contact Dermatitis. 2011;64:363–4.
Harber P, Su J, Alongi G. Beryllium biobank: 2. Lymphocyte proliferation testing. J Occup Environ Med. 2014;56:857–60.
Harber P, Su J. Beryllium biobank: 3. Considerations for improving chronic beryllium disease screening. J Occup Environ Med. 2014;56:861–6.
Tinkle SS, Antonini JM, Rich BA, et al. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect. 2003;111:1202–8.
Occupational Safety and Health Administration (OSHA) US Department of Labor. Occupational exposure to beryllium. Final rule. Fed Regist. 2017;82(5):2470–24757.
Walberg JE, Bowman A. Guinea pig maximization test. In: Anderson KE, Maibach HI, editors. Contact allergy. Predictive tests in guinea pigs. Current problems in dermatology, vol. 14. Basel: Karger; 1985. p. 59–106.
Kligman AM. The identification of contact allergens by human assay. III. The maximization test: A procedure for screening and rating contact sensitizers. J Invest Dermatol. 1966;47:393–409.
Epstein WL, Byers VS. Transfer of contact sensitivity to beryllium using dialyzable leukocyte extracts (transfer factor). J Allerg Clin Immunol. 1979;63:111–5.
Borak J. Chronic beryllium disease. The search for a dose-response. J Occup Environ Med. 2016;58:e355–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Taylor, J.S., Dweik, R.A., Taylor, J.M. (2018). Metal Allergy: Beryllium. In: Chen, J., Thyssen, J. (eds) Metal Allergy. Springer, Cham. https://doi.org/10.1007/978-3-319-58503-1_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-58503-1_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-58502-4
Online ISBN: 978-3-319-58503-1
eBook Packages: MedicineMedicine (R0)